Skip to content

Intralipid in treatment of tramadol poioiiong

The effects of Intravenous fat emulsion (Intralipid) in treatment of acute tramadol poisoning

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017050120951N3
Enrollment
100
Registered
2017-05-29
Start date
2017-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute tramadol poisoning. Poisoning by narcotics and psychodysleptics [hallucinogens]

Interventions

case group: Intralipid 20% 500 cc infusion in 1-2 hours
Intervention 1: case group: Intralipid 20% 500 cc infusion in 1-2 hours. Intervention 2: control group: no drug.
Treatment - Drugs

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion: history of tramadol poisoning, presence of pertinent clinical signs and symptoms, consent for participation in the study Exclusion: co-ingestion, history of hypersensitivity to the drug, presence of a major internal disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Convulsion. Timepoint: at the time of admission and during hospital stay. Method of measurement: observation by nurse or physician.;Duration of hospitalization. Timepoint: at the time of discharge. Method of measurement: according to the hospital records.

Secondary

MeasureTime frame
Systolic blood pressure. Timepoint: during hospital admission. Method of measurement: sphygnomanimeter.;Diastolic blood pressure. Timepoint: during hospital admission. Method of measurement: sphygnomanimeter.;Heart rate. Timepoint: during hospital admission. Method of measurement: by nurse or phycician.;Serum CPK level. Timepoint: at he time of admission and 24 hours later. Method of measurement: by lab.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Mohammad Kazemifar

Qazvin University of medical Sciences

amkazemifar@qums.ac.ir+98 28 3333 2930

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026